Researchers are working to make GLP-1 medications like Ozempic and Wegovy available to consumers as pills, instead of being produced as solely inject-able treatments.

In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that ...

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in ...

They have been called miraculous and the fastest way to lose weight, but how exactly do these weight loss-drugs work – and ...

An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.